Endovascular Treatment of Cancer-Associated Venous Obstruction: Comparison of Efficacy Between Stent Alone and Stent Combined With Linear Radioactive Seeds Strand

Abstract

Objectives:

To investigate the safety and efficacy of a stent combined with a linear strand of ¹²⁵I seeds to treat malignant cancer–associated venous obstruction.

Methods:

We retrospectively analyzed the data of 57 patients with malignant cancer–associated venous obstruction. Nineteen patients underwent the placement of a stent combined with a linear strand of ¹²⁵I seeds (group A), and 38 patients underwent the placement of a bare stent (group B). The following parameters were compared between the 2 groups of patients: symptom relief rate, duration of venous patency, survival time, quality of life, and adverse events.

Results:

A total of 34 stents and 527 seeds were implanted in group A, while a total of 57 stents were implanted in group B. The surgery success rate was 96.5%, and no serious complication related to the surgery was reported. Symptoms of venous obstruction improved significantly after surgery. The score of group A decreased from 14.74 ± 0.562 points before surgery to 2.79 ± 1.357 points after surgery(P < .001), and the score of group B decreased from 13.79 ± 1.398 points before surgery to 5.55 ± 3.674 points after surgery (P < .001). The patency rate of group A was significantly higher than that of group B at 1 to 6 months after surgery (100%, 84.2%, 68.4%, 63.2%, 36.8%, 21.1% vs 68.4%, 23.7%, 18.4%, 7.9%, 5.3%, 2.6%, respectively; P < .05). Before treatment, there was no statistically significant difference in the Karnofsky Performance Status (KPS) score between the groups (P = .791). After 1 to 6 months of treatment, the KPS score was significantly higher in group A than in group B (P = .013). The median patency duration in groups A and B was 125 days (95% CI: 80.018-169.982) and 35 days (95% CI: 20.501-49.499), respectively (P < .001). The median survival time of group A was 155 days (95% CI: 110.406-199.594), and that of group B was 98 days (95% CI: 55.712-140.288; P = .325). Multivariate analysis showed that the implantation of a stent combined with a linear strand of ¹²⁵I seeds and the KPS score (≥80 points) were independent factors of long-term patency after stent placement.

Conclusions:

The placement of a stent combined with a linear strand of ¹²⁵I seeds is a safe and effective treatment for venous obstruction caused by malignant tumors. This treatment provides prolonged patency compared with the placement of bare stent, and while it does not significantly improve the survival time of patients, it can improve their quality of life.

Keywords

malignant tumors vein stent iodine seeds

Get full access to this article

View all access options for this article.

References

Fletcher

Lakin

Pommier

Wilmarth

. Results of treatment of inferior vena cava syndrome with expandable metallic stents. Arch Surg. 1998;133(9):935–938.

Teng

. Expert consensus on the standard of interventional therapy for lower extremity deep venous thrombosis (second edition). J Intervent Radiol. 2019;28(1):1–10.

Zhang

Liu

Zhang

, et al. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol. 2017;23(43):7735–7745.

Zhang

Yan

Luo

, et al. Iodine-125 seeds strand for treatment of tumor thrombus in inferior vena cava: an experimental study in a rabbit model. Cardiovasc Intervent Radiol. 2013;36(5):1371–1382.

Chen

Wang

Yan

, et al. The use of ¹²⁵I seeds strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biother Radiopharm. 2012;27(5):317–323.

Kearon

Akl

Ornelas

, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352.

Key

Khorana

Kuderer

, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496–520.

O’Sullivan

Waldron

Mannion

Keane

Donnellan

. Thrombolysis and iliofemoral vein stent placement in cancer patients with lower extremity swelling attributed to lymphedema. J Vasc Interv Radiol. 2015;26(1):39–45.

Fagedet

Thony

Timsit

, et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol. 2013;36(1):140–149.

10.

Sobrinho

Aguiar

. Stent placement for the treatment of malignant superior vena cava syndrome—a single-center series of 56 patients. Arch Bronconeumol. 2014;50(4):135–140.

11.

Yang

Yan

Luo

, et al. A pilot study of intraluminal brachytherapy using (125)I seeds strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. Brachytherapy. 2016;15(6):859–864.

12.

Zhu

Guo

Mao

, et al. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. Lancet Oncol. 2014;15(6):612–619.

13.

Wang

Liu

Zheng

, et al. Clinical study on using ¹²⁵I seeds articles combined with biliary stent implantation in the treatment of malignant obstructive jaundice. Anticancer Res. 2017;37(8):4649–4653.

14.

Wang

Guo

, et al. A novel tracheobronchial stent loaded with ¹²⁵I seeds in patients with malignant airway obstruction compared to a conventional stent: a prospective randomized controlled study. EBioMedicine. 2018;33:269–275.

15.

Yao

Liu

Sun

Wang

. Stenting of the portal vein combined with different numbers of iodine-125 seeds strands: dosimetric analyses. Chin Med J. 2017;130(18):2183–2189.

16.

Qing-Hui

Wen

Zhi-Ping

, et al. Implantation of irradiation stent combined with transarterial chemoembolization (TACE) for treatment of malignant inferior vena cava (IVC) obstruction caused by hepatic malignant tumor. Fudan Univ J Med Sci. 2014;41(5):617–623.

17.

Gong

Song

Zhao

. Intraluminal brachytherapy using a self-expandable stent loaded with linear iodine-125 seeds in a patient with reiterative recurrence of cancer-associated vein obstruction: a case report with 3 months of follow-up. Vasc Endovascular Surg. 2018;52(6):463–468.

18.

Dai

Yao

Luo

Yan

. Chemoembolization and stenting combined with iodine-125 seeds strands for the treatment of hepatocellular carcinoma with inferior vena cava obstruction. Exp Ther Med. 2015;10(3):973–977.

19.

Zhang

Yan

Luo

, et al. Iodine-125 seeds strand for treatment of tumor thrombus in inferior vena cava: an experimental study in a rabbit model. Cardiovasc Intervent Radiol. 2013;36(5):1371–1382.

20.

Hoopes

Gillette

Withrow

. Intraoperative irradiation of the canine abdominal aorta and vena cava. Int J Radiat Oncol Biol Phys. 1987;13(5):715–722.

21.

Guo

Teng

Deng

Fang

Zhu

. Esophageal intraluminal irradiation stent: primary results of development and clinical application. Chin J Radiol. 2004;38(9):916–920.

22.

Huimin

Zhang

Ding

Sui

Wang

Juan

. Esophageal stent covered with radioactive ¹²⁵I seeds arranged at different distance: dosimetric comparison study. J Intervent Radiol. 2015;24(4):338–341.

23.

Yang

Luo

Liu

. Dosimetry of consecutive linear arranged ¹²⁵I seeds. J Intervent Radiol. 2015;24(1):59–63.